Piper Sandler lowered the firm’s price target on Braze (BRZE) to $27 from $30 to reflect the general software de-rating, while keeping an Overweight rating on the shares. The firm notes Braze was up 19% in after-hours trading after management guided the initial FY27 revenue midpoint to 20% year-over-year growth, well ahead of consensus expectations for 17% year-over-year.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRZE:
- Braze price target lowered to $40 from $45 at Goldman Sachs
- Braze price target raised to $31 from $29 at Barclays
- Braze price target lowered to $40 from $43 at Canaccord
- Braze price target lowered to $35 from $68 at Citizens
- Braze: Accelerating Fundamentals, Strengthened Outlook, and Attractive Risk-Reward Support Buy Rating